Topic:
Genomics
Latest Headlines
Latest Headlines
Genomics? There could be an app for that
Individualized medicine based on genomics is about to hit the masses, Wired predicts, and that could mean storing genetics data on your smart phone in the not-so-distant future.
CLC bio capitalizes on surge in DNA sequencing
CLC bio wants the world to know that business is good, but the world might be more interested in why its business has taken off. The Danish provider of bioinformatics software touts today that its software sales shot up 30% in 2012 with an equal jump in its number of employees.
Biotech mogul combines drugs and IT to attack cancer
The biotech landscape is covered with startup efforts with cancer drugs, but when Dr. Patrick Soon-Shiong announces one, the business world stops and listens.
Cypher Genomics chief speaks out from DNA data-crunching crowd
Is genome interpretation approaching "bubble" status as startups rise all around to find what matters in massive amounts of DNA data? Bio-IT World editor and genomics chronicler Kevin Davies questioned the chief executive of one of the higher-profile outfits from the field, Cypher Genomics, to find out what makes the startup stand out from the crowd.
Salk Institute gets $42M grant to study chronic diseases, establish new genomic center
The La Jolla, CA-based Salk Institute for Biological Studies has landed a $42 million grant to establish the Helmsley Center for Genomic Medicine. The award, from The Leona M. and Harry B. Helmsley Charitable Trust, is the biggest in Salk's history.
Illumina, Life Technologies trumpet startup efforts in clinical genomics
The network effect could bring genomics into the mainstream of healthcare and aid drug development. Two rival leaders in the DNA sequencing arena--Illumina and Life Technologies--have forged separate alliances with major medical institutions to bring the power of decoding genomes into the clinic.
Quants collaborate on forecasting value of genomics in medicine
Genomics hasn't lived up to all the hype in medicine, and even some experts have begun to question the value of the field. Channeling Nate Silver, Harvard researchers took a data-driven approach used in forecasting the weather and outcomes of presidential elections to forecast the value of genomics research.
Study: Genomics, outsourcing fuel double-digit growth in bioinformatics
The bioinformatics market is on track for sizable growth over the next 6 years, with heavy demand from researchers in genomics and biopharma, according to a new report from Transparency Market Research.
23andMe sets stage for stronger ties with pharma
Anne Wojcicki co-founded 23andMe in 2006 with the big idea that informing patients about their genetics would empower them to take control of their health destinies rather than becoming slaves to the healthcare system. With more than 180,000 people who have had 23andMe analyze their genes, Wojcicki has turned the big idea into reality for many of those who have used its personal genomics service.
Read the feature >>
UCSF highlights genomics and bioinformatics work
Researchers have tapped bioinformatics to study human genes and the environment, seeking a better understanding of breast cancer and sheep flatulence (seriously).
